{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:21:40Z","timestamp":1779366100882,"version":"3.53.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.transci.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T02:02:25Z","timestamp":1385604145000},"page":"644-646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immature platelet fraction can help adjust therapy in refractory thrombotic microangiopathic hemolytic anemia cases"],"prefix":"10.1016","volume":"49","author":[{"given":"Yelena E.","family":"Kier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Stempak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Maitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.07.005_b0005","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"96","author":"George","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.07.005_b0010","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2141.1994.tb05122.x","article-title":"Anti-CD36 antibodies in thrombotic thrombocytopenic purpura","volume":"88","author":"Tandon","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2013.07.005_b0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.transci.2013.07.005_b0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2004.04987.x","article-title":"Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia","volume":"126","author":"Briggs","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2013.07.005_b0025","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1111\/j.1751-553X.2010.01232.x","article-title":"The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation","volume":"32","author":"Yamaoka","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.transci.2013.07.005_b0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1309\/AJCPPNF63FLIORCI","article-title":"Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults","volume":"133","author":"Park","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.transci.2013.07.005_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-8722-1-23","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP\u2013HUS): a 24-year clinical experience with 178 patients","volume":"1","author":"Levandovsky","year":"2008","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.transci.2013.07.005_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1179\/102453311X12902908411995","article-title":"Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center","volume":"16","author":"Kim","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.transci.2013.07.005_b0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.07.005_b0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.thromres.2005.09.007","article-title":"A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)","volume":"118","author":"Abe","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2013.07.005_b0055","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1182\/blood-2010-11-321398","article-title":"Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia","volume":"117","author":"Barsam","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.07.005_b0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2008.01156.x","article-title":"Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis","volume":"82","author":"Sugimori","year":"2009","journal-title":"Eur J Haematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213002322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213002322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:12:16Z","timestamp":1597101136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213002322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1473050213002322"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.07.005","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immature platelet fraction can help adjust therapy in refractory thrombotic microangiopathic hemolytic anemia cases","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}